Description
CD79a antibody is an intracellular component of the signal transduction pathway of the B-cell Receptor, appearing at pre-B-cell stage and persisting until the plasma cell stage. Studies have shown that CD79a is found in a majority of acute leukemia of precursor-B-cell-type as well as B-cell neoplasms, B-cell lymphomas and some myelomas. It is not present in myeloid or T-cell lines. This antibody labels precursor B-cell acute lymphoblastic leukemia, and has been suggested as the most reliable B-cell marker for this disorder. CD79a is conserved across species, which may make it useful in the identification of B-cell lymphomas in species other than human.
SPECIFICATIONS
Specifications
| WEIGHT | N/A |
|---|---|
| DIMENSIONS | N/A |
| INTENDED USE | IVD |
| SPECIES REACTIVITY | Human, Rat |
| SOURCE | Mouse Monoclonal |
| CLONE | HM47/A9 |
| ISOTYPE | IgG1 /kappa |
| ANTIGEN | CD79a |
| LOCALIZATION | Cell Membrane |
| POSITIVE CONTROL | Germinal center B-cells in lymph node or tonsil. |
DATASHEETS & SDS
INTERNATIONAL
REFERENCES
1. Milner RJ, et al. Onderstepoort J Vet Res. 1996 Dec; 63(4):309-313.
2. Astsaturov IA, et al. Leukemia. 1996 May; 10(5):769-73.
3. Chetty R, et al. J Clin Pathol. 1995 Nov; 48(11):1035-8.
4. Hemsley SW, et al. Immunol Cell Biol. 1995 Aug; 73(4):321-5.
5. Mason DY, et al. Blood. 1995 Aug; 86(4):1453-9.
Reviews
There are no reviews yet.